rs770962467
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_024915.4(GRHL2):c.1081G>A(p.Val361Met) variant causes a missense change. The variant allele was found at a frequency of 0.00000549 in 1,457,222 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_024915.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 28Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AD Classification: STRONG Submitted by: ClinGen
- posterior polymorphous corneal dystrophyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
- nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital fibrosis of extraocular musclesInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRHL2 | NM_024915.4 | c.1081G>A | p.Val361Met | missense_variant | Exon 8 of 16 | ENST00000646743.1 | NP_079191.2 | |
GRHL2 | NM_001330593.2 | c.1033G>A | p.Val345Met | missense_variant | Exon 8 of 16 | NP_001317522.1 | ||
GRHL2 | NM_001440448.1 | c.1033G>A | p.Val345Met | missense_variant | Exon 8 of 16 | NP_001427377.1 | ||
GRHL2 | NM_001440447.1 | c.1081G>A | p.Val361Met | missense_variant | Exon 8 of 16 | NP_001427376.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRHL2 | ENST00000646743.1 | c.1081G>A | p.Val361Met | missense_variant | Exon 8 of 16 | NM_024915.4 | ENSP00000495564.1 | |||
GRHL2 | ENST00000395927.1 | c.1033G>A | p.Val345Met | missense_variant | Exon 8 of 16 | 2 | ENSP00000379260.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251314 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000549 AC: 8AN: 1457222Hom.: 0 Cov.: 29 AF XY: 0.00000414 AC XY: 3AN XY: 725310 show subpopulations
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Val361Met variant in GRHL2 has not been previously reported in individuals with hearing loss, but has been identified in 3/126630 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs770962467). Although this variant has been seen in the general population, it s frequency is not high enough to rule out a pathogenic role. Computational pred iction tools and conservation analysis suggest the variant may impact the protei n, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Val361Met variant is uncertain. A CMG/AMP Criteria applied: PM2, PP3. -
not provided Uncertain:1
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Autosomal dominant nonsyndromic hearing loss 28 Uncertain:1
Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as 3B-VUS. Following criteria are met: 0103 - Both loss- and gain-of-function are known mechanisms of disease for this gene. Variants causing autosomal dominant deafness and autosomal recessive ectodermal dysplasia/short stature syndrome are due to a loss of function, however variants observed in autosomal dominant corneal dystrophy result in a gain of function (OMIM). (N) 0108 - This gene is known to be associated with both recessive and dominant disease. Deafness and corneal dystrophy are both dominantly inherited, whereas ectodermal dysplasia/short stature syndrome is a recessive condition (OMIM). (N) 0200 - Variant is predicted to result in a missense amino acid change from valine to methionine (exon 8). (N) 0251 - Variant is heterozygous. (N) 0302 - Variant is present in gnomAD (v2) <0.001 (3 heterozygotes, 0 homozygotes). (P) 0502 - Missense variant with conflicting in silico predictions and/or uninformative conservation. (N) 0600 - Variant is located in an annotated domain or motif (CP2 transcription factor domain; NCBI, PDB). (N) 0705 - No comparable variants have previous evidence for pathogenicity. (N) 0808 - Previous reports of pathogenicity are inconclusive. The variant has previously been classified as a VUS (ClinVar). (N) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at